Industries > Pharma > Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies

PUBLISHED: 04 March 2020
PAGES: 179
PRODUCT CODE: PHA0629
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1

covid-19

Market Dynamics
• Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
• Increasing outsourcing of biopharmaceuticals-related manufacturing activities
• Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
• Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
• Uptake of single-use production systems by the biopharmaceutical manufacturing industry
• Asia emerging as hot destination for biopharmaceutical manufacturing
• Increasing confidence of pharmaceutical industry in CDMOs capabilities
• High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fueling the growth of biopharma-specific CMOs/CDMOs
• Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
• Increasing shortage of skilled workforce in the biopharmaceutical industry
• Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth
• Complicated and stringent regulatory requirements hinder market growth

Market Segmentation 2020-2030
Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis.

Service

• Process Development
– Downstream
– Upstream

• Fill & Finish Operations
• Analytical & Quality Control Studies
• Packaging

Product

• Biologics
– Monoclonal Antibodies (MAbs)
– Recombinant Proteins
– Vaccines
– Insulin

• Biosimilars

Regional Breakdown
Focused regional forecasts and analysis explore the future opportunities:

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

• North America
– U.S.
– Canada

• Europe
– UK
– France
– Germany
– Russia
– Rest of Europe

• Asia-Pacific
– China
– Japan
– India
– Southeast Asia
– Rest of Asia Pacific

• Latin America
– Brazil
– Argentina
– Rest of Latin America

• Middle East & Africa
– GCC
– South Africa
– Rest of Middle East

Buy our report today Biopharmaceuticals Contract Manufacturing Market: Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories